Terminal Arteriolar Network Structure/Function and Plasma Cytokine Levels in db/db and ob/ob Mouse Skeletal Muscle

Microcirculation

Volumn 18, Issue 3, 2011, Pages 238-251

  Georgi, Melissa K ^a   Vigilance, Jacqueline ^b   Dewar, Anthony M ^a   Frame, Mary D ^a  

^a St Francis Hospital The Heart Center   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Inflammation; Metabolic disorder; Oxygen delivery; Plasma cytokines

Indexed keywords

CYTOKINE; PENTOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; ERYTHROCYTE; INFLAMMATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE OXYGENATION;

ANIMALS; ARTERIOLES; CYTOKINES; DIABETES MELLITUS; ERYTHROCYTES; INFLAMMATION; MICE; MICE, MUTANT STRAINS; MICE, OBESE; MUSCLE, SKELETAL; OXYGEN;

MUS;

EID: 79953000868     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2011.00084.x     Document Type: Article

References (81)

1. Alì G, Boldrini L, Lucchi M, Picchi A, Dell'Omodarme M, Prati MC, Mussi A, Corsi V, Fontanini G. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. Br J Cancer 101: 1869-1875, 2009.
2. Aplin AC, Fogel E, Nicosia RF. MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model. Angiogenesis 13: 219-226, 2010, doi: .
3. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5: 384-394, 1973.
4. Banks AS, Davis SM, Bates SH, Myers MG. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275: 14563-14572, 2000.
5. Barcelos LS, Coelho AM, Russo RC, Guabiraba R, Souza ALS, Bruno-Lima G, Proudfoot AEI, Andrade SP, Teixeira MM. Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc Res 78: 148-154, 2009.
6. BenEzra D, Griffin BW, Maftzir G, Aharonov O. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci 34: 3601-3608, 1993.
7. Berg BR, Sarelius IH. Functional capillary organization in striated muscle. Am J Physiol 268: H1215-H1222, 1995.
8. Berne R. Berne & Levy Physiology, 6th edn. Philadelphia, PA: Mosby/Elsevier, 2010.
9. Bohlen HG, Niggl BA. Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice. Blood Vessels 16: 269-276, 1979.
10. Burgess JK, Boustany S, Moir LM, Weckmann M, Lau JY, Grafton K, Baraket M, Hansbro PM, Hansbro NG, Foster PS, Black JL, Oliver BG. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness. Am J Respir Crit Care Med 181: 106-115, 2010.
11. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98: 6390-6395, 2001.
12. Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 183: 4705-4714, 2009.
13. Chen J, Stinnett A. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 57: 3335-3343, 2008.
14. Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, Szurszewski JH, Gibbons SJ, Farrugia G. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology 138: 2399-2409, 2409.e1, 2010.
15. Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 154: 34-41, 2006.
16. Courtice FC. The blood volume of normal animals. J Physiol (Lond) 102: 290-305, 1943.
17. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 10: 742-780, 1997.
18. Currie C, Morgan C, Peters J. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 21: 42-48, 1998.
19. Davies M, Lund R, Mathew S, Hruska K. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16: 917-928, 2005.
20. Dentelli P, Del Sorbo L, Rosso A, Molinar A, Garbarino G, Camussi G, Pegoraro L, Brizzi MF. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. J Immunol 163: 2151-2159, 1999.
21. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54: 619-624, 2009.
22. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94: 2157-2163, 2009.
23. Dube MG, Torto R, Kalra SP. Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin-deficient diabetic obese mice. Peptides 29: 593-598, 2008.
24. Emanueli C, Caporali A, Krankel N, Cristofaro B, Van Linthout S, Madeddu P. Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia. Front Biosci 12: 2003-2012, 2007.
25. Emanueli C, Salis M, Pinna A, Stacca T, Milia A, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation 106: 993-999, 2002.
26. Entabi F, Albadawi H, Stone DH, Sroufe R, Conrad MF, Watkins MT. Hind limb ischemia-reperfusion in the leptin receptor deficient (db/db) mouse. J Surg Res 139: 97-105, 2007.
27. Fang Y, Shen J, Yao M, Beagley K, Hambly B, Bao S. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br J Dermatol 162: 478-486, 2010.
28. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239, 2006.
29. Fisman EZ, Adler Y, Tenenbaum A. Biomarkers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 45: 44-64, 2008.
30. Fox RJ, Frame MD. Arteriolar flow recruitment with vitronectin receptor stimulation linked to remote wall shear stress. Microvasc Res 64: 414-424, 2002.
31. Gómez-Ambrosi J, Catalán V, Rodríguez A, Ramírez B, Silva C, Gil MJ, Salvador J, Frühbeck G. Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem 21: 774-780, 2010.
32. Goodwill AG, Frisbee SJ, Stapleton PA, James ME, Frisbee JC. Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation 16: 667-684, 2009.
33. Gove ME, Rhodes DH, Pini M, van Baal JW, Sennello JA, Fayad R, Cabay RJ, Myers MG, Fantuzzi G. Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice. J Leukoc Biol 85: 491-496, 2009.
34. Hill MA, Simpson BE, Meininger GA. Altered cremaster muscle hemodynamics due to disruption of the deferential feed vessels. Microvasc Res 39: 349-363, 1990.
35. Hofmann S, Dong H, Li Z, Cai W, Altomonte J, Thung S, Zeng F, Fisher E, Vlassara H. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51: 2082-2089, 2002.
36. Igel M, Becker W, Herberg L, Joost HG. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology 138: 4234-4239, 1997.
37. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 260: H1713-H1717, 1991.
38. Imhof BA, Aurrand-Lions M. Angiogenesis and inflammation face off. Nat Med 12: 171-172, 2006.
39. Kamiya A, Ando J, Shibata M, Wakayama H. The efficiency of the vascular-tissue system for oxygen transport in the skeletal muscles. Microvasc Res 39: 169-185, 1990.
40. Kim G, Lee J, Ryu H, Wei J, Seong C, Kim J. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol 184: 3946-3954, 2010.
41. Ko S, Cao W, Liu Z. Hypertension management and microvascular insulin resistance in diabetes. Curr Hypertens Rep 12: 243-251, 2010.
42. Kyzer S, Binyamini J, Chaimoff C, Fishman P. The effect of surgically induced weight reduction on the serum levels of the cytokines: interleukin-3 and tumor necrosis factor. Obes Surg 9: 229-234, 1999.
43. Lin C, Shyu K, Wang B, Chang H, Chen Y, Chiu J. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach. J Agric Food Chem 58: 7082-7087, 2010.
44. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55: 500-507, 2010.
45. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC, Gauldie J. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 160: 2285-2294, 2002.
46. Meagher C, Arreaza G, Peters A, Strathdee CA, Gilbert PA, Mi Q, Santamaria P, Dekaban GA, Delovitch TL. CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes 56: 809-817, 2007.
47. Mentor-Marcel RA, Bobe G, Barrett KG, Young MR, Albert PS, Bennink MR, Lanza E, Colburn NH. Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev Res (Phila Pa) 2: 60-69, 2009.
48. Milkiewicz M, Brown MD, Egginton S, Hudlicka O. Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 8: 229-241, 2001.
49. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 52: 119-123, 2001.
50. Mustafa SS, Rivers RJ, Frame MD. Microcirculatory basis for nonuniform flow delivery with intravenous nitroprusside. Anesthesiology 91: 723-731, 1999.
51. Nishigaki K, Faber JE, Ohyanagi M. Occlusion of cremaster collateral circulation alters microvascular reactivity. Microvasc Res 41: 173-183, 1991.
52. Oakes N, Thalen P, Aasum E, Edgley A, Larsen T, Furler S, Ljung B, Severson D. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Am J Physiol Endocrinol Metab 290: E870-E881, 2006.
53. Okon EB, Szado T, Laher I, McManus B, van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
54. Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. AJP: Heart Circ Physiol 295: H1982-H1988, 2008.
55. Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res 11: 78, 2010.
56. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58: 718-725, 2009.
57. Pickens SR, Volin MV, Mandelin AM, Kolls JK, Pope RM, Shahrara S. IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol 184: 3233-3241, 2010.
58. Pini M, Fantuzzi G. Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J Leukoc Biol 87: 51-58, 2010.
59. Priestman D, Spoel A, Butters T, Dwek R, Platt F. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Diab Obes Metab 10: 159-166, 2008.
60. Qian L, Wang H, Qiu W, Huang H, Bruce IC, Xia Q. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats. Vasc Pharmacol 45: 374-382, 2006.
61. Remick D. Cytokines in Health and Disease, 2nd edn. NY: M. Dekker, 1997.
62. Rumore-Maton B, Elf J, Belkin N, Stutevoss B, Seydel F, Garrigan E, Litherland SA. M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice. Clin Dev Immunol 2008: 769795, 2008.
63. Sarelius IH, Duling B. Direct measurement of microvessel hematocrit, red cell flux, velocity, and transit time. Am J Physiol Heart Circ Physiol 243: H1018-H1026, 1982.
64. Simpson PB, Mistry MS, Maki RA, Yang W, Schwarz DA, Johnson EB, Lio FM, Alleva DG. Cutting edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. J Immunol 171: 3333-3337, 2003.
65. Sokal R. Biometry: The Principles and Practice of Statistics in Biological Research, 3rd edn. NY: W.H. Freeman, 1995.
66. Soltesz P, Der H, Veres K, Laczik R, Sipka S, Szegedi G, Szodoray P. Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) 47: 1628-1634, 2008.
67. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817, 2003.
68. Srinivasan S, Bolick DT, Hatley ME, Natarajan R, Reilly KB, Yeh M, Chrestensen C, Sturgill TW, Hedrick CC. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem 279: 31930-31936, 2004.
69. Stapleton PA, Goodwill AG, James ME, D'Audiffret AC, Frisbee JC. Differential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice. Microcirculation 17: 47-58, 2010.
70. Surmi BK, Webb CD, Ristau AC, Hasty AH. Absence of macrophage inflammatory protein-1{alpha} does not impact macrophage accumulation in adipose tissue of diet induced obese mice. Am J Physiol Endocrinol Metab 299: E437-E445, 2010, doi: .
71. Sweeney T, Sarelius IH. Arteriolar control of capillary cell flow in striated muscle. Circ Res 64: 112-120, 1989.
72. Sweeney TE, Sarelius IH. Spatial heterogeneity in striated muscle arteriolar tone, cell flow, and capillarity. Am J Physiol 259: H124-H136, 1990.
73. Talavera-Adame D, Xiong Y, Zhao T, Arias AE, Sierra-Honigmann MR, Farkas DL. Quantitative and morphometric evaluation of the angiogenic effects of leptin. J Biomed Opt 13: 064017, 2008.
74. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581, 2006.
75. Tran ED, Schmid-Schönbein GW. An in-vivo analysis of capillary stasis and endothelial apoptosis in a model of hypertension. Microcirculation 14: 793-804, 2007.
76. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh PF. Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J Diabetes Complicat 18: 343-351, 2004.
77. Winters B, Mo Z, Brooks-Asplund E, Kim S, Shoukas A, Li D, Nyhan D, Berkowitz DE. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 89: 2382-2390, 2000.
78. Wolf U, Wolf M, Choi J, Levi M, Choudhury D, Hull S, Coussirat D, Paunescu L, Safonova L, Michalos A, Mantulin W, Gratton E. Localized irregularities in hemoglobin flow and oxygenation in calf muscle in patients with peripheral vascular disease detected with near-infrared spectrophotometry. J Vasc Surg 37: 1017-26, 2000., 2003.
79. Yamaji-Kegan K, Su Q, Angelini DJ, Johns RA. IL-4 is proangiogenic in the lung under hypoxic conditions. J Immunol 182: 5469-5476, 2009.
80. Zemse SM, Hilgers RHP, Webb RC. Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings. Am J Physiol Heart Circ Physiol 292: H3103-H3108, 2007.
81. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84: 272-278, 1999.